维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Cryan SA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Chitosan for gene delivery and orthopedic tissue engineering applications显示文摘	Raftery R O'Bfien FJ Cryan SA	2013	Molecules2013，18，5：	1
2	Inhalable siRNA : potential as a therapeutic agent in the lungs显示文摘	Durcan N Murphy C Cryan SA	2008	Mol Pharm2008，5，4：	1
3	Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding显示文摘	Taggart CC Cryan SA Weldon S	2005	J Exp Med2005，202，12：	1
4	Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding 显示文摘	Taggart CC Cryan SA Weldon S	2005	J Exp Med2005，202，12：	1
5	The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation显示文摘	Shoyele SA Sivadas N Cryan SA		0，，01：	1
6	Chitosan for gene delivery and orthopedic tissue engineering applications显示文摘	Raftery R O'Brien FJ Cryan SA	2013	Molecules2013，18，5：	1
7	Chitosan for gene delivery and orthopedic tissue engineering applications 显示文摘	Raftery R O'Brien FJ Cryan SA	2013	Molecules2013，18，5：	1
8	Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding显示文摘	Taggart CC Cryan SA Weldon S	2005	J Exp Med2005，202，12：	1
9	Carrier-based Strategies for Tmgeting Protein and Peptide Drugs to the Lungs显示文摘	Cryan SA	2005	AAPS J2005，7，1：	1
10	Secretory leucoprotease in- hibitor binds to NF-kappa B binding sites in monocytes and inhibits p65 binding 显示文摘	Taggart CC Cryan SA Weldon S	2005	J Exp Med2005，202，12：	1
11	Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65binding显示文摘	Taggart CC Cryan SA Weldon S	2005	J Exp Med2005，202，12：	1
12	A dry powder formulation of liposome-cneapsulated recombinant secretory leu- kocyte protease inhibitor (rSLPI) for inhalation: preparation and characterization显示文摘	GIBBONS A MCELVANEY NG CRYAN SA	2010	AAPS Pharm Sci Tech2010，11，2：	1
13	Inhalable siRNA: po- tential as a therapeutic agent in the lungs显示文摘	Durcan N Murphy C Cryan SA	2008	Mol Pharm2008，5，4：	1
14	Inhalatlle siRNA : potential as a therapeutic agent in tile lungs显示文摘	Durcan N Murphy C Cryan SA	2008	Mol Pharn12008，5，4：	1
15	Inhalable siRNA : potential as a ther- apentie agent in the lungs显示文摘	Durcan N Murphy C Cryan SA	2008	Mol Pharm2008，5，4：	1
16	Chitosan for gene deliv-ery and orthopedic tissue engineering applications 显示文摘	Raftery R Obrien FJ Cryan SA	2013	Molecules2013，18，5：	1
17	Inhalable siRNA: potential as a tberapentic agent in the lungs 显示文摘	Durean N Murphy C Cryan SA	2008	Mol Pharrn2008，5，4：	1
18	Secretory leucopro- tease inhibitor binds to NF-kappaB binding sites in mono- cytes and inhibits p65 binding显示文摘	Taggart CC Cryan SA Weldon S	2005	J Exp Med2005，202，12：	1
19	Chitosan for gene delivery and orthopedic tissue engineering applications显示文摘	Raftery Rj O'Brien FJ Cryan SA	2013	Molecules2013，18，5：	1
20	Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding 显示文摘	Taggart CC Cryan SA Weldon S	2005	J Exp Med2005，202，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示